. Parpi, DPQ: 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)- isoquinolinone; ANI: 4-amino-1,8-naphthalimidecan; PHHs: Primary human hepatocytes; PCR: Polymerase chain reaction; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; SNP: Single nucleotide polymorphism

. Hbsag, HBV surface antigen; pADPr: ADP-ribose polymers

J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer, vol.8, issue.19, pp.2893-2917, 2010.
DOI : 10.1002/ijc.25516

C. De-lope, S. Tremosini, A. Forner, M. Reig, and J. Bruix, Management of HCC, Journal of Hepatology, vol.56, issue.56, pp.75-87
DOI : 10.1016/S0168-8278(12)60009-9

P. Merle, F. Mornex, and C. Trepo, Innovative therapy for hepatocellular carcinoma: Three-dimensional high-dose photon radiotherapy, Cancer Letters, vol.286, issue.1, pp.129-133, 2009.
DOI : 10.1016/j.canlet.2008.12.004

F. Mornex, N. Girard, C. Beziat, A. Kubas, M. Khodri et al., Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies???mature results of the French Phase II RTF-1 trial, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.4, pp.1152-1158, 2006.
DOI : 10.1016/j.ijrobp.2006.06.015

N. Curtin, DNA repair dysregulation from cancer driver to therapeutic target, Nature Reviews Cancer, vol.68, issue.12, pp.801-817, 2012.
DOI : 10.1038/nrc3399

D. Vos, M. Schreiber, V. Dantzer, and F. , The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art, Biochemical Pharmacology, vol.84, issue.2, pp.137-146, 2012.
DOI : 10.1016/j.bcp.2012.03.018

R. Krishnakumar and W. Kraus, The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets, Molecular Cell, vol.39, issue.1, pp.8-24, 2010.
DOI : 10.1016/j.molcel.2010.06.017

F. Megnin-chanet, M. Bollet, and J. Hall, Targeting poly(ADP-ribose) polymerase activity for cancer therapy, Cellular and Molecular Life Sciences, vol.68, issue.Pt 2, pp.3649-3662, 2010.
DOI : 10.1007/s00018-010-0490-8

G. Noel, C. Godon, M. Fernet, N. Giocanti, F. Megnin-chanet et al., Radiosensitization by the poly(ADP-ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA synthesis, Molecular Cancer Therapeutics, vol.5, issue.3, pp.564-574, 2006.
DOI : 10.1158/1535-7163.MCT-05-0418

F. Dungey, D. Loser, and A. Chalmers, Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.4, pp.1188-1197, 2008.
DOI : 10.1016/j.ijrobp.2008.07.031

C. Godon, F. Cordelieres, D. Biard, N. Giocanti, F. Megnin-chanet et al., PARP inhibition versus PARP-1 silencing: different outcomes in terms of single-strand break repair and radiation susceptibility, Nucleic Acids Research, vol.36, issue.13, pp.4454-4464, 2008.
DOI : 10.1093/nar/gkn403

T. Pawlik and K. Keyomarsi, Role of cell cycle in mediating sensitivity to radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.4, pp.928-942, 2004.
DOI : 10.1016/j.ijrobp.2004.03.005

C. Calabrese, R. Almassy, S. Barton, M. Batey, A. Calvert et al., Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361, JNCI Journal of the National Cancer Institute, vol.96, issue.1, pp.56-67, 2004.
DOI : 10.1093/jnci/djh005

M. Ali, B. Telfer, C. Mccrudden, M. O-'rourke, H. Thomas et al., Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?, Clinical Cancer Research, vol.15, issue.19, pp.6106-6112, 2009.
DOI : 10.1158/1078-0432.CCR-09-0398

S. Liu, C. Coackley, M. Krause, F. Jalali, N. Chan et al., A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia, Radiotherapy and Oncology, vol.88, issue.2, pp.258-268, 2008.
DOI : 10.1016/j.radonc.2008.04.005

D. Davar, J. Beumer, L. Hamieh, and H. Tawbi, Role of PARP Inhibitors in Cancer Biology and Therapy, Current Medicinal Chemistry, vol.19, issue.23, pp.3907-3921
DOI : 10.2174/092986712802002464

R. Quiles-perez, J. Munoz-gamez, A. Ruiz-extremera, O. Valle, F. Sanjuan-nunez et al., Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression, Hepatology, vol.39, issue.Suppl 1, pp.255-266, 2010.
DOI : 10.1002/hep.23249

J. Munoz-gamez, R. Quiles-perez, A. Ruiz-extremera, A. Martin-alvarez, L. Sanjuan-nunez et al., Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells, Cancer Letters, vol.301, issue.1, pp.47-56, 2011.
DOI : 10.1016/j.canlet.2010.10.026

C. Guillot, J. Hall, Z. Herceg, P. Merle, and I. Chemin, Update on hepatocellular carcinoma breakthroughs: Poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy, Clinics and Research in Hepatology and Gastroenterology, vol.38, issue.2, pp.137-142, 2014.
DOI : 10.1016/j.clinre.2013.07.006

P. Gripon, S. Rumin, S. Urban, L. Seyec, J. Glaise et al., Nonlinear partial differential equations and applications: Infection of a human hepatoma cell line by hepatitis B virus, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15655-15660, 2002.
DOI : 10.1073/pnas.232137699

J. Millau, A. Raffin, S. Caillat, C. Claudet, G. Arras et al., A microarray to measure repair of damaged plasmids by cell lysates, Lab on a Chip, vol.43, issue.10, pp.1713-1722, 2008.
DOI : 10.1039/b806634e

C. Prunier, G. Masson-genteuil, N. Ugolin, F. Sarrazy, and S. Sauvaigo, Aging and photo-aging DNA repair phenotype of skin cells???Evidence toward an effect of chronic sun-exposure, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.736, issue.1-2, pp.48-55, 2012.
DOI : 10.1016/j.mrfmmm.2011.05.005

T. Zaremba, P. Ketzer, M. Cole, S. Coulthard, E. Plummer et al., Poly(ADP-ribose) polymerase-1 polymorphisms, expression and activity in selected human tumour cell lines, British Journal of Cancer, vol.65, issue.2, pp.256-262, 2009.
DOI : 10.1016/0167-4889(93)90179-S

X. Wang, Z. Wang, W. Tong, and Y. Shen, PARP1 Val762Ala polymorphism reduces enzymatic activity, Biochemical and Biophysical Research Communications, vol.354, issue.1, pp.122-126, 2007.
DOI : 10.1016/j.bbrc.2006.12.162

K. Lockett, M. Hall, J. Xu, S. Zheng, M. Berwick et al., The ADPRT V762A Genetic Variant Contributes to Prostate Cancer Susceptibility and Deficient Enzyme Function, Cancer Research, vol.64, issue.17, pp.6344-6348, 2004.
DOI : 10.1158/0008-5472.CAN-04-0338

M. Teo, D. Landi, C. Taylor, F. Elliott, L. Vaslin et al., The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes, Carcinogenesis, vol.33, issue.3, pp.581-586, 2012.
DOI : 10.1093/carcin/bgr300

V. Ossovskaya, I. Koo, E. Kaldjian, C. Alvares, and B. Sherman, Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types, Genes & Cancer, vol.1, issue.8, pp.812-821, 2010.
DOI : 10.1177/1947601910383418

M. Rouleau, M. El-alfy, M. Levesque, and G. Poirier, Assessment of PARP-3 Distribution in Tissues of Cynomolgous Monkeys, Journal of Histochemistry & Cytochemistry, vol.48, issue.7, pp.675-685, 2009.
DOI : 10.1369/jhc.2009.953380

I. Bieche, V. Pennaneach, K. Driouch, S. Vacher, T. Zaremba et al., Variations in the mRNA expression of poly(ADP-ribose) polymerases, poly(ADP-ribose) glycohydrolase and ADP-ribosylhydrolase 3 in breast tumors and impact on clinical outcome, Int J Cancer, vol.133, pp.2791-2800, 2013.

H. Ko, H. Ng, E. Goh, and E. Ren, Reduced ADP-ribosylation by PARP1 natural polymorphism V762A and by PARP1 inhibitors enhance Hepatitis B virus replication, Journal of Viral Hepatitis, vol.56, issue.1, pp.658-665, 2013.
DOI : 10.1111/jvh.12100

J. Zhang, D. Li, A. He, M. Motwani, V. Vasiliou et al., Synergistic inhibition of hepatocellular carcinoma growth by cotargeting chromatin modifying enzymes and poly (ADP-ribose) polymerases, Hepatology, vol.65, issue.6, pp.1840-1851, 2012.
DOI : 10.1002/hep.25566